BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7377155)

  • 21. Tetanus toxoid as an antigen for delayed cutaneous hypersensitivity.
    Delafuente JC; Eisenberg JD; Hoelzer DR; Slavin RG
    JAMA; 1983 Jun; 249(23):3209-11. PubMed ID: 6343648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen specific stimulation of immune responses during long-term repeated skin testing with multiple antigens.
    Lesourd BM; Winters WD; Darnell B
    J Clin Lab Immunol; 1986 Sep; 21(1):17-22. PubMed ID: 2433448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed-type hypersensitivity in palmoplantar pustulosis: effect of cyclosporin A treatment on skin testing with recall antigens.
    Remitz A; Lauerma AI; Erkko P; Reitamo S
    Acta Derm Venereol; 1996 Jul; 76(4):310-3. PubMed ID: 8869692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed cutaneous hypersensitivity response in tetanus toxoid sensitized rhesus monkeys: predictor of anergy and value in tuberculin skin testing.
    Davis JA; Hayre M; Linn JM
    Lab Anim Sci; 1988 Aug; 38(4):413-6. PubMed ID: 3184848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-mediated immunity assessed by Multitest CMI skin testing in infants and preschool children.
    Kniker WT; Lesourd BM; McBryde JL; Corriel RN
    Am J Dis Child; 1985 Aug; 139(8):840-5. PubMed ID: 4025264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vaccination against diphtheria and tetanus of children with thymus hyperplasia syndrome].
    Ozeretskovskiĭ NA; Martynova MI; Shishatskaia SN; Kova'lskaia SIa; Veĭsfeĭler OIu; Vaganov PD; Mikheeva IG
    Pediatriia; 1989; (9):26-31. PubMed ID: 2587163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diphtheria-tetanus overimmunization in children with no records: can it be prevented?
    Frank JW; Schabas R; Arshinoff R; Brant R
    CMAJ; 1989 Dec; 141(12):1241-6. PubMed ID: 2590890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmentation of humoral and cellular immunity in response to Tetanus and Diphtheria toxoids by supercritical carbon dioxide extracts of Hippophae rhamnoides L. leaves.
    Jayashankar B; Singh D; Tanwar H; Mishra KP; Murthy S; Chanda S; Mishra J; Tulswani R; Misra K; Singh SB; Ganju L
    Int Immunopharmacol; 2017 Mar; 44():123-136. PubMed ID: 28092864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunity against diphtheria and tetanus in various age groups after 40 years since implementation of the mass vaccination program].
    Fordymacka A
    Przegl Epidemiol; 2000; 54(3-4):333-41. PubMed ID: 11349596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dot immunoassay for the simultaneous determination of postvaccination immunity against pertussis, diphtheria, and tetanus.
    Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
    Anal Bioanal Chem; 2017 Jun; 409(15):3831-3842. PubMed ID: 28374129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.
    McCusker C; Somerville W; Grey V; Mazer B
    Ann Allergy Asthma Immunol; 1997 Aug; 79(2):145-50. PubMed ID: 9291419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic responses following serial skin testing.
    Steele RW; Crabtree BL; Smith GR; Marmer DJ
    J Immunol Methods; 1986 Feb; 86(2):213-6. PubMed ID: 3944474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of immunological function in clinical medicine.
    Forbes IJ
    Aust N Z J Med; 1971 May; 1(2):160-70. PubMed ID: 5284552
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the adequate composition of diphtheria and tetanus toxoids-with reference to the amounts of toxoids and aluminum adjuvant.
    Someya S; Mizuhara H; Murata R; Kurokawa M
    Jpn J Med Sci Biol; 1981 Feb; 34(1):21-35. PubMed ID: 7265558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative clinical study of Adsorbed Tetanus Vaccine and Adult-type Tetanus-Diphtheria Vaccine.
    Deacon SP; Langford DT; Shepherd WM; Knight PA
    J Hyg (Lond); 1982 Dec; 89(3):513-9. PubMed ID: 7153515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated immunity in schoolchildren assessed by multitest skin testing. Normal values and proposed scoring system for healthy children.
    Corriel RN; Kniker WT; McBryde JL; Lesourd BM
    Am J Dis Child; 1985 Feb; 139(2):141-6. PubMed ID: 3976586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody production following immunization with diphtheria and tetanus toxoids in children receiving chemotherapy during remission of malignant disease.
    Kung FH; Orgel HA; Wallace WW; Hamburger RN
    Pediatrics; 1984 Jul; 74(1):86-9. PubMed ID: 6588361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypersensitivity to tetanus toxoid.
    Facktor MA; Bernstein RA; Fireman P
    J Allergy Clin Immunol; 1973 Jul; 52(1):1-12. PubMed ID: 4268453
    [No Abstract]   [Full Text] [Related]  

  • 39. [Intracutaneous test using diphtheria-tetanus toxoid for study of cellular immunity].
    John M; Rumler W
    Dtsch Med Wochenschr; 1978 Jul; 103(29):1182-3. PubMed ID: 668556
    [No Abstract]   [Full Text] [Related]  

  • 40. Diphtheria and tetanus toxoids.
    Smith JW
    Br Med Bull; 1969 May; 25(2):177-82. PubMed ID: 4918532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.